Radiation exposure to families of patients following administration of 177Lu-DOTATATE for the treatment of metastatic neuroendocrine tumours
Implementing standardised contact restrictions for patients and their family members following <sup>177</sup>Lu-DOTATATE PRRT limits the dose received by family members to less than 5 mSv in 5 years, ensuring sufficient protection and compliance with the UK legislation.
Authors
- Eleni Kalogianni
- D. Levart (ORCID: https://orcid.org/0000-0001-5893-0700)
- Neil Heraghty
- Susanne Wicks
- Nicola Mulholland (ORCID: https://orcid.org/0000-0003-0912-9890)
Institutions
- Leeds Teaching Hospitals NHS Trust (GB)
- King's College Hospital NHS Foundation Trust (GB)
Publication Details
- Journal
- EJNMMI Physics
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1186/s40658-025-00776-x
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- King's College London